David Charles Lyden

Weill Cornell Medicine

NIH Rank #3316
  • R01 Holder
  • Early Career
  • Diverse Portfolio

NIH Funding · FY2024

Total Funding
$2.6M
Fiscal year 2024
Grants Awarded
5
Active NIH grants
National Rank
#3,316
Among 57,894 PIs
First NIH Award
2024
Year of first funding

Funding & rank history

NIH funding totals and national rank by fiscal year.

Single fiscal year on record (FY2024): $2.6M across 5 grants · National rank #3316.

Top grants by award amount

David Charles Lyden's NIH grant portfolio, ranked by award amount.

  • 5R35CA232093-07R35
    Systemic regulation of metastasis
    $960.7K
    award amount
  • 5R01DK137517-02R01
    Abnormal Extracellular Vesicles and Particles from Human Islets Impact T1D progression
    $678.6K
    award amount
  • 5R01CA218513-07R01
    Application of 4D proteomics and super-resolution microscopy in extracellular vesicle and particle-borne biomarker discovery for early pancreatic cancer detection
    $454K
    award amount
  • 5R33HL154310-04R33
    In vitro modeling of blood brain barrier dysfunction on a chip to elucidate the pathogenesis of cerebral malaria
    $429.6K
    award amount
  • 2U19AI144301-06U19
    Immune Cells and Secretory Pathways Leading to Human Systemic Autoimmunity
    $113.7K
    award amount

Affiliation

Institutions that have administered grants for David Charles Lyden.

Affiliated with Weill Cornell Medicine (NY).

Career milestones

Key NIH funding milestones over time.

  1. 2024
    First NIH Award
    Weill Cornell Medicine
  2. 2024
    $500K Cumulative Funding
  3. 2024
    $1M Cumulative Funding
  4. 2024
    $2M Cumulative Funding
  5. 2024
    Entered Top 50% Nationally
    Ranked #3316
  6. 2024
    Entered Top 25% Nationally
    Ranked #3316